Arch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code…
<!-- Name:DistributionId Value:8784862 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
AC5
Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022…
FRAMINGHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and…
Arch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors at 2022…
FRAMINGHAM, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and…
Arch Therapeutics Submits Application to Centers for Medicare and Medicaid Services…
FRAMINGHAM, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and…